Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
35.42
-0.39 (-1.09%)
Dec 20, 2024, 4:00 PM EST - Market closed
Agios Pharmaceuticals Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$56.33
Upside
+59.03%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Dec 18, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $55 → $57 | Buy | Maintains | $55 → $57 | +60.93% | Dec 10, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $53 → $75 | Buy | Maintains | $53 → $75 | +111.74% | Dec 9, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $55 | Buy | Reiterates | $55 | +55.28% | Nov 1, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $51 → $53 | Buy | Maintains | $51 → $53 | +49.63% | Nov 1, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $51 | Buy | Initiates | $51 | +43.99% | Oct 16, 2024 |
| Raymond James | Raymond James | Buy Initiates $51 | Buy | Initiates | $51 | +43.99% | Oct 10, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $60 → $56 | Buy → Hold | Downgrades | $60 → $56 | +58.10% | Sep 27, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 20, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $55 | Buy | Reiterates | $55 | +55.28% | Sep 19, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $53 → $55 | Buy | Maintains | $53 → $55 | +55.28% | Aug 2, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 17, 2024 |
| JP Morgan | JP Morgan | Hold Initiates $46 | Hold | Initiates | $46 | +29.87% | Jun 13, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $33 → $53 | Hold | Maintains | $33 → $53 | +49.63% | Jun 4, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $44 → $53 | Buy | Maintains | $44 → $53 | +49.63% | Jun 4, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $29 → $33 | Hold | Maintains | $29 → $33 | -6.83% | May 3, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.